Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
2751
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.23M | ﹤0.01% |
315,061
-1,040,034
| -77% | -$15M |
|
2752
Credicorp
BAP
$29.5B
| $4.23M | ﹤0.01% |
28,672
+26,410
| +1,168% | +$3.62M |
|
2753
PUT
Lightspeed Commerce
LSPD
$1.38B
| $4.23M | ﹤0.01% |
+250,000
| New | +$3.59M |
|
2754
HEICO Corp
HEI
$46.4B
| $4.22M | ﹤0.01% |
23,867
-96,591
| -80% | -$16.3M |
|
|
FORG
2755
DELISTED
ForgeRock, Inc.
FORG
| $4.21M | ﹤0.01% |
204,961
-46,780
| -19% | -$937K |
|
2756
PUT
Molson Coors Class B
TAP
$7.7B
| $4.21M | ﹤0.01% |
63,900
-200
| -0.3% | -$12.4K |
|
2757
Advance Auto Parts
AAP
$2.6B
| $4.21M | ﹤0.01% |
59,824
-1,448,903
| -96% | -$149M |
|
2758
PUT
ARK Blockchain & Fintech Innovation ETF
ARKF
$822M
| $4.2M | ﹤0.01% |
+201,000
| New | +$3.82M |
|
2759
PUT
Nasdaq
NDAQ
$55.7B
| $4.2M | ﹤0.01% |
84,300
-23,300
| -22% | -$1.26M |
|
2760
Nice
NICE
$6.36B
| $4.2M | ﹤0.01% |
20,335
+5,003
| +33% | +$1.03M |
|
2761
CALL
Lantheus
LNTH
$6.56B
| $4.2M | ﹤0.01% |
+50,000
| New | +$4.49M |
|
2762
Kura Oncology
KURA
$1.13B
| $4.19M | ﹤0.01% |
396,171
+374,981
| +1,770% | +$4.43M |
|
|
AIRC
2763
DELISTED
Apartment Income REIT Corp.
AIRC
| $4.19M | ﹤0.01% |
116,084
+46,470
| +67% | +$1.66M |
|
2764
PUT
PENN Entertainment
PENN
$2.33B
| $4.19M | ﹤0.01% |
174,300
-17,800
| -9% | -$474K |
|
2765
PUT
Williams Companies
WMB
$90.4B
| $4.18M | ﹤0.01% |
128,200
+52,900
| +70% | +$1.59M |
|
2766
CALL
Canadian Natural Resources
CNQ
$101B
| $4.18M | ﹤0.01% |
+148,600
| New | +$4.24M |
|
2767
Lindblad Expeditions
LIND
$1.98B
| $4.18M | ﹤0.01% |
384,100
-415,565
| -52% | -$4.27M |
|
2768
Sabre
SABR
$892M
| $4.17M | ﹤0.01% |
1,308,685
+409,647
| +46% | +$1.48M |
|
2769
CALL
Norfolk Southern
NSC
$77.9B
| $4.17M | ﹤0.01% |
18,400
-79,100
| -81% | -$16.8M |
|
2770
Clover Health Investments
CLOV
$2.25B
| $4.17M | ﹤0.01% |
4,650,918
+4,631,050
| +23,309% | +$4.11M |
|
2771
CALL
Arcus Biosciences
RCUS
$3.76B
| $4.17M | ﹤0.01% |
205,300
+95,300
| +87% | +$1.81M |
|
|
BSAQ
2772
DELISTED
Black Spade Acquisition Co
BSAQ
| $4.16M | ﹤0.01% |
402,616
+34,916
| +9% | +$359K |
|
2773
PUT
YPF Sociedad Anonima ADS
YPF
$19.9B
| $4.16M | ﹤0.01% |
+279,400
| New | +$3.39M |
|
2774
Aldeyra Therapeutics
ALDX
$91.1M
| $4.16M | ﹤0.01% |
495,575
-622,856
| -56% | -$6.14M |
|
2775
Codexis
CDXS
$176M
| $4.16M | ﹤0.01% |
1,484,928
+1,178,757
| +385% | +$3.81M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.